Pfizer - TrumpRx deal boosts Big Pharma to a record rally
Source: SeekingAlpha
2025-10-04 09:59:31 ET
More on Pfizer, VanEck Pharmaceutical ETF, etc.
- Why Eli Lilly Is The Lion's Share Of My Portfolio
- PPH: The Big Pharma ETF
- Pfizer: The Long Suffering Is Finally Over (Rating Upgrade)
- INCY and ABBV lead S&P 500 healthcare gainers in Q3; MOH and ALGN lag
- Novo’s Wegovy and Lilly’s Zepbound recommended in Europe as first-line obesity treatments
Read the full article on Seeking Alpha
For further details see:
Pfizer – TrumpRx deal boosts Big Pharma to a record rally
Bausch Health Companies Inc.
NASDAQ: BHC:CC
BHC:CC Trading
-0.34% G/L:
$5.88 Last:
1,784,767 Volume:
$5.90 Open:
BHC:CC Latest News
February 23, 2026 08:00:00 am
Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada
February 19, 2026 08:00:00 am
Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres
